Viral gastroenteritis accounts for enormous morbidity and mortality in
children throughout the world, This year, trials with live vaccines a
gainst the most serious pathogen of viral gastroenteritis, rotavirus,
showed promise of reasonable efficacy in the developed world. More bas
ic studies in rotavirus immunology and biology are outlining the basis
of immune resistance to disease and leading toward new effective vacc
ine strategies. The development of recombinant Norwalk virus and relat
ed calicivirus antigens and polymerase chain reaction assays is revolu
tionizing our understanding of the epidemiology and pathophysiology of
these ubiquitous microbes. The role of viruses such as astrovirus, ad
enoviruses, and picobirnaviruses in diarrheal disease among immunocomp
romised and normal hosts continues to be proved. Further refinement of
oral rehydration therapy will hopefully further decrease the morbidit
y and mortality of viral diarrheal disease.